인터베스트

인터베스트 discloses dealings in 3 companies, chiefly 에임드바이오, 파이버프로 and 메쥬. We count 9 filings; the first trade dates from 4 December 2025 and the latest from 7 April 2026.

Both buying and selling appear: 4 purchases worth €494k, against 5 sales worth €69.6M. The totals exclude 6 filings filed without an amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2026 alone, the filings show 2 purchases and 5 sales.

On 14 April 2026 came the latest disclosure, an open-market sale for €636k in 파이버프로. The latest purchase dates back some time: it was published 194 days ago, on 14 April 2026. Typically, a trade is published a median of 7 days after it takes place. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.